Current theories envision recovery from local anesthetic block of sodium channels via slow hydrophilic and fast hydrophobic paths. Extracellular pH reduction which increases cationic/neutral anesthetic form should especially prolong recovery kinetics of highly lipid soluble compounds that could readily exit via the hydrophobic pathway at normal extracellular pH. To test this hypothesis, we compared the effects of three related compounds with similar pKa on the time course of V max reactivation in guinea pig papillary muscle at pH<, 7.4 and 6.95. The compounds were lidocaine and its two desethylation products, monoethylglycinexylidide and glycinexylidide. Judged from the octanol:water partition coefficient, lidocaine was the most lipid soluble (log partition coefficient 2.39 ± 0.10), followed by monoethylglycinexylidide (log partition coefficient 1.32 ± 0.09) and glycinexylidide was the least lipid soluble (log partition coefficient 0.41 ± 0.09). At 30 MM and pHo 7.4, the potency order for W mix depression at zero diastolic interval was lidocaine (53 ± 6%), monoethylglycinexylidide (17 ± 3%), and then glycinexylidide (7.8 ± 1.9%). The decay of V^ block appeared monoexponential, and the time constant of recovery was dose independent. Most important is the fact that there were significant differences in the r r increase with extracellular pH reduction (P < 0.05; Scheffe contrasts). The increase was greatest with lidocaine [73 ± 28% (mean ± SD)], less with monoethylglycinexylidide (42 ± 15%), and least with glycinexylidide (13 ± 17%). The simplest interpretation of the differences in extracellular pHdependence of recovery kinetics was that recovery from block due to the neutral form of these ionizable local anesthetics depended on lipid solubility, whereas recovery from block due to the protonated form depended on molecular weight. (Circ Res 55: 513-523, 1984) 
SUMMARY. Current theories envision recovery from local anesthetic block of sodium channels via slow hydrophilic and fast hydrophobic paths. Extracellular pH reduction which increases cationic/neutral anesthetic form should especially prolong recovery kinetics of highly lipid soluble compounds that could readily exit via the hydrophobic pathway at normal extracellular pH. To test this hypothesis, we compared the effects of three related compounds with similar pKa on the time course of V max reactivation in guinea pig papillary muscle at pH<, 7.4 and 6.95. The compounds were lidocaine and its two desethylation products, monoethylglycinexylidide and glycinexylidide. Judged from the octanol:water partition coefficient, lidocaine was the most lipid soluble (log partition coefficient 2.39 ± 0.10), followed by monoethylglycinexylidide (log partition coefficient 1.32 ± 0.09) and glycinexylidide was the least lipid soluble (log partition coefficient 0.41 ± 0.09). At 30 MM and pHo 7.4, the potency order for W mix depression at zero diastolic interval was lidocaine (53 ± 6%), monoethylglycinexylidide (17 ± 3%), and then glycinexylidide (7.8 ± 1.9%). The decay of V^ block appeared monoexponential, and the time constant of recovery was dose independent. Most important is the fact that there were significant differences in the r r increase with extracellular pH reduction (P < 0.05; Scheffe contrasts). The increase was greatest with lidocaine [73 ± 28% (mean ± SD)], less with monoethylglycinexylidide (42 ± 15%), and least with glycinexylidide (13 ± 17%). The simplest interpretation of the differences in extracellular pHdependence of recovery kinetics was that recovery from block due to the neutral form of these ionizable local anesthetics depended on lipid solubility, whereas recovery from block due to the protonated form depended on molecular weight. (Circ Res 55: 513-523, 1984) IONIZABLE antiarrhythmic drugs such as lidocaine possess the useful property of more potent electrophysiological action in ischemic than in normal myocardium (Kupersmith et al., 1975; Hille, 1978; Hondeghem, 1976; Allen et al., 1978; Lazzara et al., 1978; Cardinal et al., 1981) . This potentiation has been attributed in part to an increase in H + concentration within ischemic areas (Kupersmith et al., 1975) . Measurements of phase 0 V^, reactivation in guinea pig papillary muscle (Grant et al., 1980) and sodium conductance reactivation in voltageclamped nerve, skeletal muscle, and Purkinje fibers (Khodorov et al., 1976; Schwarz et al., 1977; Bean et al., 1982) indicate that recovery from local anesthetic sodium channel block is delayed by extracellular pH reduction. Acidosis is thought to increase the proportion of channels occupied by the protonated form of the local anesthetic base (Kupersmith et al., 1975; Schwarz et al., 1977) . Experiments with permanently charged quaternary amine local anesthetics in nerve and heart indicate that hydrophilic protonated drug molecules unblock with much slower kinetics than more lipid-soluble neutral forms (Strichartz, 1973; Schwarz et al., 1977; Gin-tant et al., 1983) . The kinetic difference has been attributed to the very large difference in lipid solubility (Hille, 1977; Schwarz et al., 1977; Courtney, 1980) . However, studies examining heterogeneous groups of local anesthetic amines at normal pH have produced conflicting conclusions as to the importance of lipid solubility in determining recovery kinetics (Courtney, 1980; Campbell, 1983) . If lipid solubility is of pivotal importance, pH reduction should especially prolong recovery kinetics of compounds with highly lipid-soluble neutral form, since these would readily unblock via the membrane phase at normal pH. We thought it would be of advantage to restrict the comparison to a small group of related compounds with different lipid solubility and similar values for pK a ; we therefore chose to examine the electrophysiological properties of lidocaine and its two desethylation products, monoethylglycinexylidide (MEGX) and glycinexylidide (GX). Dealkylation is expected to reduce lipid solubility (Hansch and Leo, 1979) . We were particularly interested in determining whether there was a corresponding reduction in the pH dependence of recovery kinetics.
The cellular electrophysiological properties of MEGX and GX have not previously been described. They have been shown to accumulate in the plasma of patients and dogs receiving lidocaine and to partition into the myocardium to an extent similar to lidocaine Halkin et al., 1975; Handel et al., 1983 ). MEGX appears to possess antiarrhythmic and convulsant properties comparable to lidocaine, whereas GX appears considerably less potent (Smith and Duce, 1971; Blumer et al., 1974; Tenthorey et al., 1981) . We determined lipid solubility by octanol:H 2 O partition coefficient (P). The kinetics of recovery from block of phase 0 V max were assessed by determining the time constant of recovery (r r ) in guinea pig papillary muscle at normal and low pH using conventional microelectrodes.
Methods

Tissue Preparation and Apparatus
Guinea pigs (250-350 g) were stunned and the hearts rapidly removed and dissected in room temperature-oxygenated Krebs-Henseleit solution. Right ventricular papillary muscles (0.8-1.0 mm in diameter) were mounted in a three-compartment sucrose gap chamber. The length of muscle in the test chamber was limited to 0.5-1.0 mm (Reuter and Scholz, 1968 ). The 0.7-ml capacity test compartment was perfused at 3 ml/min. Bath temperature was monitored by thermister (YSI no. 511 probe) and controlled to 36 ± 1°C. The preparation was stimulated with constant current pulses, 2 msec in duration. Pulse amplitude was that required to maintain constant latency (usually 2 msec) between end of stimulus and peak upstroke velocity of the action potential. Transmembrane potential was recorded differentially between two glass microelectrodes containing 3 M KC1 (resistance 15-30 Mfi). In most experiments, the microelectrode tips were beveled to reduce resistance to 15-20 MQ. One electrode impaled the cell and the other was positioned in close proximity just above the tissue surface. The microelectrodes were coupled via Ag/AgCI half-cells (WPI EH-3FS) to matched voltage followers having high input impedance (10 10 Q) and input capacity neutralization. The output of the voltage followers was amplified by the 3A9 differential amplifier of a Tektronix 565 oscilloscope. The maximum rate of rise of the transmembrane potential (V^*) was obtained by electronic differentiation (differentiator output linear over the range 10-1000 V/sec). Oscilloscope traces of the action potential and its time derivative were photographed by a Grass C4 camera and enlarged (8x) for analysis by projection onto a digitizing tablet.
Solutions
Under control conditions, the anterior (test) compartment was perfused with Krebs-Henseleit (K-H) solution at pH 7.4, containing (ITIM): NaCl, 118; NaHCO 3 , 21; KC1, 4.3; MgSO 4 , 1.2; glucose, 11. The solution was gassed continuously with 95% O2, 5% CO2 starring 10 minutes before the addition of CaCh. To test the effects of acidosis, we reduced pH to 6.95 by replacing all but 7.5 rrtM NaHCO 3 with NaCl. The pH of the solution was titrated to 7.4 or 6.95 by the addition of HC1 or NaOH, using a high precision pH analyzer (IL Inc., model 113). Preliminary experiments showed that solution pH remained constant from solution reservoir to anterior chamber; we Circulation Research/Vo/. 55, No. 4, October 1984 routinely monitored reservoir pH, not anterior chamber pH, to avoid disturbing the preparation. Acidosis increases ionized calcium activity (Spitzer and Hogan, 1979) . The present pH reduction increased the ionized calcium activity of our K-H solution from 1.41 ± 0.01 to 1.57 ± 0.01 mM (mean ± SD, n = 3). We decided not to reduce the calcium concentration of the pH 6.95 solutions to counteract this change, since no such compensation would occur in vivo.
The middle compartment was perfused with isotonic sucrose solution containing 0.01 mM CaCl 2 and gassed with 100% O2. The posterior (current-injecting) compartment was perfused with isotonic KC1 solution produced by substitution of all NaCl in the standard K-H solution.
Procedures
An initial 60-minute equilibration period in control solution was allowed. Once a stable impalement had been obtained, action potential characteristics and V max recovery kinetics were recorded. Recordings were repeated after 30, 60, and 120 minutes of exposure to lidocaine, MEGX, and GX, respectively. Only one drug was tested in each preparation. The metabolites, being less lipid soluble, required longer exposure times to produce a stable effect than did lidocaine. The basic drive stimulus (SI) was delivered in repetitive 10-beat trains at 1 Hz separated by 2-second pauses. By definition, diastole began when phase 3 repolarization had returned the membrane potential to 1 mV from its resting value. To determine recovery kinetics, a test stimulus (S2) was introduced at varying diastolic intervals following successive trains. Any reduction in V max of the test action potential was expressed as a fraction of the amplitude during the preceding basic drive action potential according to the expression: fractional V max reduction, (b) = (V maxS i -V maxS 2)/V mai< si. Since V max reactivation followed a single exponential in the present experiments, the decay of b from its value at zero diastolic interval (b 0 ) is given by b (t) = b 0 exp (-t/r,), where T, is the time constant of reactivation. Thus b decays linearly over time in a semilogarithmic plot. After logarithmic transformation of b, linear regression techniques were used to obtain least squares estimates of b 0 and the slope (regression coefficient) of the decay. r r is simply the inverse slope.
It was easier to measure the kinetics of recovery from lidocaine block of V max than metabolite block, because of lidocaine's greater potency. With GX, the least potent, it was necessary to average =5 replications at each diastolic interval to obtain a sufficiently noise-free estimate of the time course of V max reactivation. This approach was used in all GX experiments and some MEGX experiments. However, our criteria for adequate kinetics determination (see Statistical Analysis) could be satisfied for MEGX and lidocaine without the use of replication.
In some preparations, the effects of two concentrations of a single drug were examined (15 and 30 /IM lidocaine or MEGX; 30 and 120 //M GX). To test the effects of low HCO3 acidosis in drug-free solution and during exposure to drug, the sequence of pH 7.4 and 6.95 solutions was: pH 7.4 (60 minutes), pH 6.95 (20 minutes), pH 7.4 (20 minutes), pH 7.4 with drug (30, 60, or 120 minutes for lidocaine, MEGX or GX, respectively), pH 6.95 with drug (20 minutes), pH 7.4 with drug again (60 minutes). Because of the difficulty in maintaining long impalements, it was often not possible to record the entire sequence within the one cell. Partial experiments are reported pro-vided data were collected from the same cell before and during the particular intervention being examined. That is, a return to pre-intervention conditions was not always possible. 515 
Results
Octanol:H 2 O Partitioning
Differences in lipid solubility between lidocaine and its two metabolites were assessed by comparison of octanol:water partition coefficients. Partitioning was examined 2 pH units above, and 2 pH units below, drug pK a to reflect properties of neutral and charged drug molecules, respectively. Siliconized 15-ml glass test tubes containing cross-saturated octanol (2 ml) and water (2 ml) were gently rocked for 1 hour at 23°C after the addition of drug. The water was pipetted off after centrifugation at 1500 rpm for 5 minutes. Initial aqueous phase drug concentration (=167 Mg/ml) and final aqueous concentration after partitioning were measured by reverse phase ion-pair HPLC (Laboratory Data Control, model 1204A; 4.6 mm X 25 cm, Zorbax ODS column). The mobile phase contained 4.52 g NaH 2 PO 4 , 10 ml triethylamine (Aldrich), and 130 ml acetonitrile (Fisher Scientific, HPLC grade). Mobile phase pH was lowered to 3.0 with phosphoric acid before the addition of acetonitrile. The mobile phase was pumped at 1.9 ml/min, and the UV detector was set to measure absorbance at 200 nm. Estimates of drug concentration were the average of five replications.
Statistical Analysis
Student's f-test for paired data was used to assess the significance of pairwise comparisons within cells (resting membrane potential before and during drug exposure, or at two different pH values, etc.). The value during an experimental intervention was compared to the average of the value before and the value following recovery if both were available-otherwise, to the value beforehand.
To compensate for simultaneous multiple comparisons, for example, when assessing the effect of GX 30 /xM on resting potential, action potential duration and steady state V ma », a method analogous to the Bonferroni method, was used (Wallenstein et al., 1980) . The probability value corresponding to the non-modified f-statistic for the difference between each pair of means was found to three significant figures by linear interpolation using logarithms of the standard two-tailed probability values (Rohlf and Sokal, 1969) . A significance level of P < 0.05/m was used, where m = number of simultaneous comparisons. P values are reported together with their correction factor when derived from paired f-tests (e.g., P < 0.05/3).
One-way analysis of variance was used to assess the significance of differences in recovery kinetics across the three drugs, since the data were obtained in separate cell populations. Scheffe's method was used to correct for the multiple pairwise comparisons among lidocaine and the two metabolites (Wallenstein et al., 1980) . Experimental noise sometimes prevented reliable estimates of recovery kinetics being obtained. Linear regression techniques were used to eliminate from analysis experiments with unacceptable variance of the In bdiastolic interval relation [correlation coefficient <0.9, or regression coefficient not significant at the 1 % level (Snedecor and Cochran, 1967) ]. Regression analysis was also used to assess the significance of any change in T,, since this reflected a change in regression coefficient. Here, we obtained the F ratio of the residual mean square variance when one slope, as opposed to two slopes, was fitted to the data (Snedecor and Cochran, 1967) .
Steady-State Action Potential Characteristics
As expected at pH,, 7.4,15 nu lidocaine shortened action potential duration (P < 0.05/3; Table 1 ). However, resting potential and steady-state V^x remained closely similar to the lidocaine-free values at the stimulation rate of 1 Hz, consistent with previous reports (see Chen et al., 1975) . Neither 15 tiM MEGX nor 30 MM GX had any effect on these three variables. No further changes were observed after doubling the dose of lidocaine (n = 6) and MEGX (n = 7) or quadrupling the dose of GX (n = 3). Reducing pH o to 6.95 increased action potential duration significantly, both under drug-free conditions and during exposure to lidocaine and MEGX (P < 0.01/3; Table 2 ). A similar increase with acidosis during exposure to GX approached, but did not reach, statistical significance (3P = 0.062). pH<, reduction produced a small decline in steady-state V max which was significant with lidocaine (-11%) and MEGX (-14%), but not under drug-free conditions or GX exposure (Table 2) . pH o reduction also produced a small reduction in resting potential in the absence and presence of drug, but the change was statistically significant only when drug-free and drug results were pooled (1.4 mV, P < 0.01/3, n = 26).
V max Reactivation
Drug-Free Conditions
At pH o 7.4, V max recovery was virtually complete (>98%) by the time membrane potential had repolarized to 1 mV from its resting value. The subsequent small residual recovery approached experimental noise. In 25 muscles, control time constants of V max reactivation were not calculable in 23 (<20 msec). In the remaining two muscles, the values were 26 and 36 msec. pHo reduction to 6.95 had little effect on reactivation kinetics (« = 8). Recovery may have been slightly prolonged (e.g., Fig. 1 , panel Results are mean ± SD in control solution, average change in absolute units with drug. RMP, resting membrane potential; APD, action potential duration until repolarization to 1 mV from RMP; Vouu, maximum upstroke velocity of action potential.
* P < 0.05/3 for difference from control. Results are means ± SD at pH 7.40, average change in absolute units at pH 6.95. Abbreviations as in Table 1. * P < 0.01/3; t P < 0.05/3 for difference between the values at each pH.
3) but could not be quantified in five of eight muscles (Fig. 1, panels 1 and 2) .
Drug Exposure
At pH o 7.4, Vmax recovery was delayed by exposure to both metabolites, as well as to lidocaine itself. There were marked differences among the three compounds in the level of V max block present at the beginning of diastole, and moderate differences in the subsequent time course of unblocking (Fig. 2) . The order of potency for fractional Vb lock at zero diastolic interval (b 0 ) was lidocaine 15 MM (b 0 = 0.43 ± 0.08, n = 12), MEGX 30 »M (b 0 = 0.17 ± 0.03, n = 10), and then GX 30 m (b 0 = 0.078 ± 0.019, n = 10). These differences were significant at the 1% level (one-way analysis of variance; Scheffe contrasts). As can be seen from Figure 2 , unblocking following the train on average proceeded most rapidly with lidocaine (P < 0.05), then with GX, and least rapidly with MEGX (P < 0.01). An increase in dose of the three compounds increased b 0 but did not alter the kinetics of V max reactivation ( Fig. 3 ; Table 3 ). To determine how closely recovery from lidocaine block approximated a monoexponential decay, recovery kinetics were determined particularly in an additional 18 muscles. The V max measurements at each coupling interval were averaged over five replications to minimize variance from experimental noise. The relationship between In b and time was linear in all cases, with the correlation coefficient averaging 0.990 (range 0.942-0.999) in the 18 experiments. Thus, the decay in V max block appeared monoexponential (Fig. 4) .
Reduction in pH o to 6.95 markedly delayed the recovery from lidocaine block, as expected (Figs. 5 and 6). The kinetics of recovery from MEGX block were also slowed significantly (P < 0.01), but to a lesser extent (P < 0.05). By contrast, recovery from GX block was not significantly affected by pH<, reduction ( Figs. 5 and 6 ). The increase in recovery time constant produced by acidosis averaged 73 ± 28% with lidocaine (P < 0.01; n = 6), 42 ± 15% with MEGX (P < 0.01; n = 9), but only 13 ± 17% with GX (P > 0.4; n = 7). The change in recovery kinetics in each individual muscle was tested by linear regression analysis. The change in slope of the linear relationship between In b and diastolic interval was significant in all six muscles exposed to lidocaine (P < 0.001 in each), in eight of nine muscles exposed to MEGX (P < 0.025 or better), but in only one of seven musles exposed to GX (P < 0.05 in this muscle).
Acidosis also reduced b 0 due to MEGX (from 0.17 ± 0.036 to 0.121 ± 0.028, P < 0.01). No comparable effect was observed with lidocaine or GX (Fig. 6) .
Octanol:H 2 O Partitioning
Considerable differences in lipid solubility of the neutral form were suggested by the partitioning differences among the three compounds in vitro at pH = pK a +2. Lidocaine was the most lipid soluble. P, the ratio of octanol:H 2 O concentrations after partitioning, was 249 ± 60 (« = 4). MEGX was next most lipid soluble, with the ratio of octanol:H 2 O concentrations averaging 21.2 ± 4.3 (n = 3). GX was the least lipid soluble (P = 2.56 ± 0.3, n = 3). Biological activity has been found to vary with log lipid solubility (Hansch and Leo, 1979; Courtney, 1980) . The differences in log P are shown in Table  4 . The value for lidocaine is almost twice that of MEGX and almost six times that of GX. Partitioning under conditions pH = pK a -2 excluded measurable Data are means ± SD; b 0 , fractional V msx block at the onset of diastole; T,, time constant for decay of V™ block. lipid solubility of the charged (protonated) form of lidocaine, MEGX, and GX.
Discussion
In the doses examined, neither lidocaine nor its desethylated metabolites, MEGX and GX, depressed phase 0 V max of the 1 Hz basic drive action potentials. However, test impulses detected significant V max block in early diastole following a 1 Hz train in the correlation coefficient (r) shows the data is well fitted  by a straight line. Calculated b at zero diastolic interval (bo) was 0.52  in this muscle. The significance of the slope value (regression coefficient) was obtained from "t" = the ratio of slope to its standard  deviation (degrees of freedom n-2; Snedecor and Cochran, 1967) 
. An individual example of lidocaine's effect on the time course of V m^ reactivation in guinea pig papillary muscle at pH 0 7.4. Reactivation was assessed by varying the coupling interval of a single "test" action potential following a 1 Hz train. Data show the timedependent decay in fractional V ma block (b), where b = [V max (1 Hz train) -V ma (test)]/]/^ (1 Hz train). Each data point is the average of five replications. The lines through the data points were fitted by the method of least squares from the regression of In b on diastolic interval. The
. The time constant of V mia reactivation (r r ) is the inverse slope.
presence of each of the three compounds. At equimolar concentration, the initial diastolic block (b 0 ) was most intense with lidocaine, of lesser intensity with MEGX, and least with GX. At 30 /IM, b 0 averaged 0.53 with lidocaine (Table 3) , 0.17-0.18 with MEGX ( Fig. 2; Table 3 ), but only 0.07-0.08 with GX ( Fig. 2; Table 3 ). These differences roughly paralleled the relative lipid solubilities of the three compounds, which presumably determined the membrane concentration of neutral anesthetic molecules adjacent to sodium channels (relative log P 1.0:0.55:0.17, for lidocaine, MEGX, and GX, respectively). It would be necessary to obtain full doseresponse curves to determine how closely potency for early diastolic block is a function of lipid solubility as assessed from octanol:H 2 O partitioning.
All three compounds slowed the kinetics of V max reactivation. Significant differences were observed in the rate of diastolic decay of V max block. At pH o 7.4, lidocaine block dissipated most rapidly (time constant r r 139 msec), followed by GX (r r 182 msec), whereas MEGX unblocked most slowly (r r 232 msec) (Fig. 2) . These differences were not a consequence of the potency differences for b 0 block. Reactivation kinetics were shown to be dose (and hence b 0 ) independent for the three compounds over the range of b 0 values from 0.08 to 0.53 (see Fig. 3 and Table  3 ).
The question then arises whether the differences in V max reactivation can be taken to indicate comparable differences in the rates of sodium channel unblocking among the three compounds. Although a close correlation between V max and peak inward sodium (I Na ) current is expected in cardiac muscle on theoretical grounds, whether V max is a reliable index of available sodium conductance (g Na ) is controversial (Cohen and Strichartz, 1977; Hondeghem, 1978; Strichartz and Cohen, 1978; Walton and Fozzard, 1979; Cohen et al., 1981; Bean et al., 1982) . Bean et al. (1982) have recently reported that, despite the precaution of constant latency, V max appeared to be a nonlinear index of g Na changes with tetrodotoxin in voltage clamp experiments. A similar nonlinear relationship between V max and g Na was obtained when the number of sodium channels available to open during a sudden depolarization was varied by using different holding potentials to 
FIGURE 5. Individual examples of the effect of extracellular pH reduction on V ma reactivation during exposure to lidocaine, MEGX, or GX. Abbreviations and method for determining recovery kinetics as in legend to Figure 4, except that data points in the left panel represent one test action potential at each diastolic interval, not the mean of five replications.
change inactivation (Cohen et al., 1984) . An important consequence predicted from their study was that the time course of reactivation measured by V max will be distorted and nonexponential (curvilinear) when the underlying recovery of g Na is exponential. In the present study at 37°C, we did not observe curvilinear V max reactivation. The kinetics we obtained closely approached monoexponential decay except for a slight deviation at the shortest coupling intervals consistent with recovery of drugfree channels (Fig. 4) . Clarification of the discrepancy between the two methods is impeded by the current difficulty of obtaining reliable measurements of sodium current in heart under the same conditions of physiological sodium concentration, membrane potential and temperature at which V max measurements are obtained.
Nonetheless, V max provides an indirect measure of sodium conductance which must be interpreted with great caution. Linear kinetics of V max reactivation are a necessary but not sufficient feature ensuring proportionality with g Na reactivation. Complex interactions of activation and inactivation gating processes producing an apparently pure semilogarithmic decay but with an incorrect slope cannot be excluded (see Bean et al., 1982) . However the b 0 independence of V max reactivation probably ensures that directional changes in the time course of sodium channel reactivation is reliably indicated.
Effects of pH, Reduction
The kinetics of recovery from lidocaine block of V max was markedly slowed by extracellular acidosis, Average time course of V^ reactivation at pH o 7.4 and 6.95 during exposure to lidocaine, MEGX, or GX. The slope and elevation of  each line are the means of the slopes and elevations at zero diastolic interval (bo) obtained in individual muscles from the regression of In b on  diastolic interval (see legend to Figure 4) . 3) * Octanol:H 2 O partition coefficient at pH = pK« + 2; five replicates each estimation, t Truant and Takman, 1969; J Johansson, 1982. as previously reported by Grant et al. (1980) . Interestingly, recovery from MEGX block was less affected, and recovery from GX block almost completely unaffected, by moderate pH,, reduction. Current theories attribute the exponential recovery of sodium conductance between action potentials to drug exiting from sodium channels (Strichartz, 1973; Courtney, 1975; Hille, 1977 Hille, , 1978 Hondeghem and Katzung, 1977) . Hydrophobic neutral drug molecules are thought to return rapidly to the membrane phase once transmembrane potential no longer favors channel occupancy; the lipid-insoluble charged form must exit via the hydrophilic channel inner mouth unless it loses its charge (Hille, 1977) . Channel-gating configuration in diastole is thought to impede escape of the charged species from the blocking position, although other explanations for slow unblocking kinetics have not been excluded. Reduction in pH o is thought to favor protonation of drug molecules within the channel to an extent dependent on drug pK a . Lidocaine, MEGX, and GX are weak bases with pK a 7.86, 8.04, and 7.68, respectively. The protonated form predominates at low pH o . However, in the present study, the alteration in recovery kinetics with pH o reduction did not correlate with the calculated change in ratio of neutral to protonated form (Table 4 ). Indeed, the calculated change was greatest with GX, which showed little or no potentiation at all. This apparent contradiction is resolved if an important role is proposed for lipid solubility in determining the unblocking rate of the neutral form (Hille, 1977; Courtney, 1980) . Thus, an increase in protonated:neutral form should especially prolong recovery kinetics of a highly lipid soluble compound like lidocaine, which could readily exit via the membrane phase at normal pH. By contrast, lipid-insoluble GX unblocked relatively slowly whether protonated or not. MEGX with intermediate lipid solubility of the neutral form showed intermediate pH potentiation as far as kinetics of unblocking are concerned.
The question arises as to whether the marked slowing of lidocaine unblocking that we observed can reasonably be attributed to the modest reduction in ratio of neutral:protonated form produced with reduction in pHo to 6.95. To clarify this question, we examined two simple kinetic alternatives. The binding of neutral and protonated drug (D n ,D c ) to a drug-free channel (U) to form a blocked channel (B n ,B c ) was restricted to the duration of the action potential and was assumed to be negligibly slow at the present micromolar concentrations once repolarization was complete.
where k is a composite rate constant term describing drug association during diastole which combines rate contants for binding, diffusion, field effect, and drug concentration; / is a composite rate constant term describing drug dissociation during diastole which combines rate constants for binding, diffusion, and field effect; and where /" » k n and 4 ^> kc in schemes 1 and 2 during diastole (Strauss et al., in press) . Fractional block at the onset of diastole (b 0 ) equaled the sum of block due to both neutral and charged species (b n + b c ). In scheme 1, the fraction of charged and neutrally blocked channels (b n and b c ) decay as independent processes. In other words, there is no conversion of B c to B n , governed by pH o . In scheme 2, interconversion between charged and neutrally blocked channels is permitted to maintain the value of R (b n /b c ) constant throughout the decay in total V max block. We assume here that ambient pH and drug pK a within a blocked channel are the same as for drug in extracellular solution, so that R = b n /b c = IOP^-P"*. The coupled scheme was thought more realistic in view of the known access of extracellular protons to the channel-binding site (Schwarz et al., 1977) and the high speed of proton transfer reactions (Bell, 1973) . As can be seen from Figure 7 , scheme 1 is unlikely to account for the pH potentiation we observed with lidocaine. Time constants for the exponential decay of neutral and protonated species block (r n , T C ) were assumed to be 50 and 500 msec, respectively. The decay in total block is biexponential with an early rapid phase due to . It is assumed that recovery from V mal block due to protonated lidocaine (LH + ) and recovery from block due to neutral lidocaine (L) occur as two independent monoexponential decays with time constants 500 and 50 msec, respectively. At zero diastolic interval, b n :b c , the ratio of block due to L and block due to LH + , is assumed to equal the ratio [L]: [LH+] in the extracellular fluid. That is, bjb c = W"'' 1 "^. The curvilinear aggregate decay in total b from a b 0 value of 0.5 at each pH was found by addition of the linear decays of b n and b c . rate constants for neutral and charged forms of lidocaine correspond to r n and T C values of 44 and 483 msec, respectively, at the resting potential of the present experiments (-82 mV). The predicted relationship between r r and R from Equation 2, assuming the above values for /" and f c for lidocaine, is shown in Figure 8 . It can be seen that recovery kinetics of V^,* block approaches the T C value as R decreases, particularly once R is less than 0.3. This would correspond to pHo at least 0.5 U below pK a . Schwarz et al. (1977) observed even more steep pH dependence of recovery from lidocaine block of I Na in frog skeletal muscle at 12.5°C.
For MEGX, the r n and T C values were 70 and 439 msec, respectively. For GX, r n was 144 msec and T C was 217 msec. The simplest interpretation of these differences is that r n decreases as lipid solubility increases, whereas r c decreases with molecular weight. However, the relation between physicochemical properties and kinetics of drug action is complex (Campbell, 1983) , and it has yet to be demonstrated that extrapolation of these conclusions beyond this small series of related low molecular weight compounds is valid. The analysis predicts unexpectedly fast recovery kinetics for the protonated tertiary amine species in view of results obtained with permanently charged quaternary compounds (Gintant et al., 1983) . The discrepancy may reflect steric hindrance from the more bulky amine region of the quaternary molecule. Bean et al. (1983) recently published data on the time course of sodium current reactivation in rabbit Purkinje fiber exposed to lidocaine under voltage clamp at pH o 7.0 recovery from neutral species block and a subsequent slow phase due to recovery from protonated species block. Our lidocaine data were much better fit by scheme 2 which, for r n <3C T C , as above, implies that a significant proportion of the decay in b c involves a hydrophobic pathway of drug egress as molecules lose their charge and exit via the mem- 
Thus, reactivation should be monoexponential with the time constant for decay in total V^ block (r r ) given by R)/(/ n R
Knowing our experimental values for r r at pH, 7.4 and 6.95, and calculating R, Equation 2 can be solved for / n and 4 giving values of 2.25 X 10" 2 and 2.07 x 10~3 msec" 1 , respectively. These dissociation . It is assumed that b n :b c , the ratio of V m4t block due to neutral drug-.block due to protonated drug within sodium channels, remains identical to the value ofR, the ratio [neutral drug]:[protonated drug] in the extracellular fluid, throughout the decay in total b. R= 10'"'''*:
and 8.1. Application of our kinetic analysis to their data also predicts relatively rapid unblocking of the protonated form of lidocaine (T C 1000 msec), but leads to a surprisingly large value for the time constant of the lipid-soluble neutral form of the molecule (r n 342 msec). This may reflect maintenance of their preparation at a temperature below the point of phase transition of membrane lipids. Further studies are required to validate the relationship between the aggregate r r and R over a wider range of R, as the estimates of dissociation rate constants for the charged and neutral forms of the compounds are sensitive to the accuracy with which the decrease in V max measures sodium channel block. Additional studies are also needed to confirm the importance of lipid solubility for pH potentiation of local anesthetic block.
Clinical Implications
Serum levels of MEGX and GX approaching or exceeding 20 JIM have been reported in human subjects receiving lidocaine infusion. Previous experimental studies suggest that this MEGX concentration would produce some antiarrhythmic effect. MEGX was reported to have about one-third the equimolar potency of lidocaine for antifibrillatory action in chloroform-exposed mice, one-half the potency for premature ventricular contraction suppression in dogs after coronary ligation, full potency for suppression of ouabain-toxic atrial arrhythmias in guinea pigs, and one-fourth the potency for block of frog sciatic nerve (Ehrenberg, 1948; Smith and Duce, 1971; Burney et al., 1974) . In comparison, we found that the level of V max block immediately after action potential repolarization was one-third of the block with lidocaine at 30 tiu concentration, similar to the reported potency ratios for nerve block and suppression of ventricular arrythmia. In addition, the kinetics of recovery from MEGX block was prolonged somewhat by acidosis, which may promote suppression of arrhythmia in ischemic myocardium. GX was reported one-fourth as potent as lidocaine in a model of ventricular arrhythmia (Tenthorey et al., 1981) , but failed to suppress ouabain-toxic atrial arrhythmias (Burney et al., 1974) . The present study suggests that its antiarrhythmic action probably is minimal at clinically observed blood levels in patients with ischemic ventricular arrhythmias, since V max block at the onset of diastole was less than onesixth that seen with lidocaine, and recovery from block was not delayed by acidosis.
